Browse Articles

Discover research articles across all indexed journals

Scalable Cr(III) Passivation Engineering for Effectively Suppressing Zinc Escape Toward Practical Ah‐Level Aqueous Zinc‐Ion Batteries

Advanced Materials Guoxing Tian, Ling Chen, Hongchao Wang et al. Jul 01, 2026 DOI: 10.1002/adma.73814

ABSTRACT The self‐corrosion of zinc anodes, caused by zinc atom escape and hydrogen evolution, remains a fundamental obstacle to the deployment of aqueous zinc‐ion batteries (AZIBs) in sustainable energy storage systems. Herein, we develop a scalable Cr(III) passivation strategy that constructs an ultrathin (∼100 nm), dense Cr 2 O 3 layer on the zinc surface, delivering the highest zinc chemical potential (6.96 eV) among various commercial passivation materials. This design establishes a steep chemical potential gradient, significantly elevating the energy barrier for zinc escape and thereby mitigating self‐corrosion under resting conditions. Moreover, strong electrostatic interactions between Cr 2 O 3 and [Zn(H 2 O) 6 ] 2+ accelerate Zn 2+ desolvation and migration, guiding zinc to deposit beneath the passivation layer while eliminating interference from solvated water molecules. Benefiting from its ability to inhibit static corrosion and stabilize the electrode interface during cycling, the electrode achieves remarkably stable operation over 7300 h. Furthermore, full‐cell integration with commercial MnO 2 shows negligible capacity fading over 200 cycles in a 1 Ah hard‐shell battery, and an unprecedented device energy density of 45 Wh kg −1 is achieved at an ultrahigh capacity up to ∼4 Ah. This work establishes an effective interfacial design that alleviates resting‐state corrosion and enhances cycling stability for promoting the practical application of AZIBs.

DNA‐Programmed Amorphous PtCu Nanohybrids With Spatially Partitioned Functions for Hydrogen Evolution

Advanced Materials Le Li, Huiyu Miao, Xiangjun Zheng et al. Jul 01, 2026 DOI: 10.1002/adma.73592

ABSTRACT Amorphous atomically thin metals offer an exceptionally high density of catalytically active sites, yet their practical electrocatalytic performance is often constrained by kinetic limitations arising from inefficient charge transport and restricted mass exchange within disordered ultrathin domains. This mismatch between local surface reactivity and macroscopic reaction kinetics represents a fundamental barrier to fully exploiting amorphous metallic catalysts. Here, we report a hierarchically integrated amorphous PtCu architecture in which atomically thin PtCu nanosheets and interconnected PtCu nanotubes are spatially interwoven to establish distinct yet strongly coupled reaction and transport domains. Within this architecture, the amorphous nanosheets function as highly active catalytic interfaces, while the contiguous nanotube network provides a continuous transport backbone that enables rapid electron percolation and efficient reactant diffusion. This deliberate functional partitioning effectively decouples surface reactivity from transport constraints, thereby alleviating the intrinsic kinetic bottlenecks of amorphous two‐dimensional metals. As a consequence, the PtCu nanotube‐nanosheet hybrid delivers markedly enhanced hydrogen evolution kinetics and Pt utilization efficiency, surpassing most reported Pt‐based electrocatalysts. More broadly, this work demonstrates that transport‐enabled structural integration can fundamentally reshape the electrocatalytic behavior of amorphous metals, establishing a transferable structural design strategy for converting atomic‐scale disorder into macroscopic catalytic efficiency.

Viral Infection‐Inspired Autonomous Detection of Fusion‐Competent Viruses for Screening and Environmental Surveillance

Advanced Materials Jae Chul Park, Yidam Song, Hyun‐Woo Choi et al. Jul 01, 2026 DOI: 10.1002/adma.202521241

ABSTRACT The persistent burden of respiratory viruses requires rapid, simple, and robust screening and environmental surveillance technologies that enable widespread and frequent testing. Importantly, these technologies should be based on infectivity‐relevant signals, as RNA detection alone has limited correlation with transmission risk. Here, we present a membrane fusion‐mediated platform that autonomously detects viruses by recapitulating the native viral entry mechanism. Fusogenic vesicles selectively fuse with fusion‐competent viral particles, triggering encapsulated CRISPR‐Cas13a components to generate fluorescent signals upon recognition of the released viral RNA. Through an autonomous workflow and accelerated signal generation within a confined vesicle, our platform achieves one‐step detection of viruses within 2 min. The assay robustly detects three major respiratory viruses, with analytical sensitivities down to 5 TCID 50 /mL for RSV and 50 TCID 50 /mL for SARS‐CoV‐2 and IAV. Clinical validation with 100 nasopharyngeal samples achieved 91.7% sensitivity. Remarkably, the sprayable format enables large‐area surveillance of surface contamination—like luminol revealing hidden bloodstains, it makes invisible viral threats visible. This approach establishes an intuitive real‐time detection platform, extending beyond clinical specimens to encompass environmental threats.

Host determinants of adjuvant chemotherapy feasibility and survival in localized upper gastrointestinal adenocarcinoma.

Journal of Clinical Oncology Belinda Jiao, Kim Anh Ma, Sami Alotaibi et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.125

125 Background: Perioperative chemotherapy improves survival in resectable gastric and gastroesophageal junction (GEJ) adenocarcinoma; however, many patients fail to initiate postoperative therapy in routine practice. Host-related determinants of adjuvant treatment feasibility and survival remain incompletely defined. Methods: We conducted a retrospective cohort study of patients with localized gastric or GEJ adenocarcinoma treated with perioperative chemotherapy and curative-intent resection at the McGill University Health Centre (2006-2025). The primary outcome was adjuvant chemotherapy initiation. Overall survival (OS) was analyzed using Kaplan-Meier and Cox proportional hazards models; prespecified 3-month landmark analyses were performed to mitigate immortal time bias. Sequential multivariable logistic models evaluated tumor variables, host factors (age, ECOG, serum albumin), and postoperative inflammatory recovery (ΔlogNLR), with incremental discrimination assessed by AUC. Results: Among 248 patients (median age 64; 85% male), 168 (67.7%) initiated adjuvant chemotherapy, which was associated with improved OS (HR 0.45; 95% CI, 0.33–0.62), including in landmark analyses. Pathology-only modeling showed modest discrimination (AUC 0.66). Addition of host factors improved discrimination (AUC 0.75); increasing age was independently associated with lower odds of initiating adjuvant therapy (OR 0.94 per year; 95% CI, 0.89–0.98), whereas higher serum albumin was independently associated with greater odds of initiation (OR 1.09 per g/L; 95% CI, 1.01–1.18). In a prespecified nested analysis among 69 patients with available longitudinal inflammatory data, model discrimination improved sequentially from AUC 0.65 to 0.77 to 0.80 with addition of host factors and ΔlogNLR. Tumor factors and chemotherapy regimen were not independently associated with adjuvant initiation after adjustment. Conclusions: In localized upper gastrointestinal adenocarcinoma, postoperative chemotherapy feasibility and survival are more strongly associated with host factors and recovery than with tumor pathology or regimen selection. These findings support perioperative optimization strategies, including nutritional support, prehabilitation, and interventions targeting systemic inflammation, to improve treatment delivery. Incorporating host vulnerability into risk stratification may refine treatment planning beyond pathological response alone. Prospective validation of dynamic inflammatory biomarkers and targeted host-directed interventions is warranted to determine whether improving treatment feasibility translates into survival benefit.

Real-world comparative safety and survival of alpelisib-fulvestrant versus capivasertib-fulvestrant in HR+/HER2− metastatic breast cancer: A propensity score–matched analysis.

Journal of Clinical Oncology Shankar Biswas, Yashasvi Srivastava, Rahul Falodia et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.46

46 Background: Alpelisib (PI3Kα inhibitor) and capivasertib (AKT inhibitor), each combined with fulvestrant, are approved options for PIK3CA/AKT pathway–altered HR+/HER2− metastatic breast cancer (MBC) after CDK4/6 inhibitor (CDK4/6i) progression. An indirect treatment comparison using SOLAR-1 and CAPItello-291 data suggested favorable PFS and safety for capivasertib-fulvestrant (CF), but no real-world head-to-head comparison exists. We conducted the first direct real-world comparative analysis of alpelisib-fulvestrant (AF) versus CF. Methods: Using the TriNetX Global Collaborative Network (171 HCOs), we identified adults with MBC (C50 + C77–C79) who initiated AF or CF, with fulvestrant within 30 days of the index drug. Propensity score matching (1:1) balanced cohorts on age, sex, race, metastatic sites, Charlson comorbidities, pre-existing diabetes, and baseline labs. Outcomes included overall survival (OS) and safety endpoints assessed via Kaplan-Meier and risk analyses. Results: After matching, 315 patients per cohort were analyzed. Median follow-up was 509 (AF) vs 251 (CF) days. OS did not differ significantly (HR 1.295; 95% CI 0.975–1.721; p=0.073). AF was associated with significantly higher metabolic, mucocutaneous toxicity, and healthcare utilization. Diarrhea, nausea, and hepatotoxicity were comparable. Conclusions: In this first real-world head-to-head comparison, AF and CF showed comparable OS, but AF was associated with significantly greater metabolic toxicity, stomatitis, ED utilization, fatigue, and weight loss. These findings complement trial-based indirect comparisons and support a more favorable real-world safety profile of CF, informing shared treatment decisions in post-CDK4/6i PIK3CA-mutated MBC. Safety outcomes after propensity score matching. Outcome AF CF RD P New-onset diabetes 24.9% 8.9% 0.160 <0.001 Hyperglycemia 31.4% 22.5% 0.089 0.035 Stomatitis 12.0% 4.1% 0.078 0.001 ED visits 32.4% 12.9% 0.196 <0.001 Fatigue 25.6% 13.9% 0.117 0.005 Weight loss 12.2% 4.8% 0.074 <0.001 Rash/dermatitis 12.3% 7.1% 0.053 0.034 Diarrhea 22.7% 22.0% 0.006 0.863 Nausea/vomiting 27.2% 26.0% 0.012 0.808 Hepatotoxicity 3.3% 4.0% −0.007 0.635

Fully Planarized Donor Enables Record‐High Efficiency for Blue Through‐Space Charge Transfer Emission

Angewandte Chemie International Edition Jun Hu, Dexia Zhou, Shanshan Liang et al. Jul 01, 2026 DOI: 10.1002/anie.4991944

ABSTRACT Through‐space charge transfer (TSCT) emitters featuring spatially separated donor‐acceptor architecture offer a promising strategy for designing thermally activated delayed fluorescence materials. However, developing high‐performance blue TSCT emitter remains challenging due to the intrinsic trade‐off between a wide bandgap and sufficient spatial electronic interactions. Herein, a fully planarized donor, in favor of strengthening spatial interactions and suppressing non‐radiative decay, is proposed to construct blue TSCT emitter. The resulting emitter exhibits an emission peak of 467 nm, a high photoluminescence quantum yield of 98% and a large reverse intersystem crossing (RISC) rate of 1.8×10 6  s −1 . Organic light‐emitting diodes based on the emitter achieve a maximum external quantum efficiency (EQE max ) of 34.0% with Commission Internationale de L'Eclairage (CIE) coordinates of (0.16, 0.29) and a maximum luminance of 21560 cd m −2 , which, to the best of our knowledge, represents the state‐of‐the‐art performances for blue TSCT emitters. Furthermore, hyperfluorescent devices employing the emitter as sensitizer demonstrate a high EQE max of 35.8% with a narrow full width at half maximum of 20 nm and CIE coordinates of (0.12, 0.14). This work demonstrates the critical importance of the fully planarized donor for developing high‐efficiency blue TSCT emitter.

Refuge limitation structures habitat use in agricultural landscapes: evidence from Sunda pangolins

Scientific Reports JiaZhen Lim, Macarena González-Abarzúa, Kar Hon Ng et al. Jul 01, 2026 DOI: 10.1038/s41598-026-60234-1

Abstract Wildlife persistence in human-modified landscapes is often inferred from habitat use, yet this assumption may overlook critical life-history constraints such as access to secure resting refuges. Using long-term Very High Frequency telemetry of eight sympatric Sunda pangolins ( Manis javanica ) in a forest–oil palm plantation mosaic in Sabah, Malaysia, we quantified denning range size, spatial overlap, sleeping site use, and reuse to evaluate how fine-scale refuge use structures space use. Denning range size and spatial overlap did not differ between forest-only and mixed forest–plantation individuals, indicating that macrohabitat context alone did not constrain denning spatial organisation. However, pangolins disproportionately used structurally enclosed sleeping sites such as tree hollows and burrows, while plantation use was largely restricted to exposed palm crowns that exhibited the lowest reuse rates. Sleeping site reuse probability was higher in forests than in plantations and was primarily structured by microhabitat type. These results demonstrate a decoupling between habitat use and functional habitat suitability, whereby animals may occupy modified landscapes while remaining dependent on a limited set of structurally stable refuges. Conservation strategies in agricultural landscapes should therefore prioritise the retention and restoration of structurally complex refuges, rather than relying solely on habitat extent or connectivity, to avoid overestimating functional habitat suitability for shelter-dependent species.

Processing Insulating CaTiO <sub>3</sub> into a High‐performance Photothermoelectric Material

Advanced Materials Jianbo Li, Jinghan Zhao, Manliu Du et al. Jul 01, 2026 DOI: 10.1002/adma.73774

ABSTRACT Photothermoelectric (PTE) detectors have attracted extensive attention due to the advantages of no external bias, negligible 1/f noise, and low fabrication cost for arrayed and miniaturized devices, and they circumvent the bandgap limitation of traditional photon detectors. However, the practical application of current mainstream PTE materials remains severely hindered by their poor high‐temperature stability, especially in harsh scenarios including high‐temperature monitoring and industrial waste‐heat detection. In this work, CaTiO 3 is selected as the PTE material owing to its outstanding high‐temperature stability, excellent chemical stability, non‐toxicity, and low cost. Nevertheless, intrinsic insulating CaTiO 3 possesses neither efficient optical absorption nor favorable thermoelectric properties. Herein, abundant oxygen vacancies are introduced to endow CaTiO 3 with broad‐spectrum optical absorption via the formation of defect energy levels within the bandgap. Meanwhile, La doping was employed to improve its thermoelectric performance. As a result, the La 0.2 Ca 0.8 TiO 3 sample achieves a responsivity of ≈300 mA W −1 and a noise level below 5 × 10 −9  W Hz −1/2 across a broad spectral range when only intrinsic resistance is considered. It well meets the application needs of harsh civilian environments with no strict requirement for response speed. This work offers a feasible strategy for developing high‐performance PTE detectors applicable to high‐temperature and harsh working conditions.

Spectrally Selective Daytime Radiative Cooling Coating

Advanced Materials Siyuan Jia, Ronghui Wu, Syeda Mishal Zahra et al. Jul 01, 2026 DOI: 10.1002/adma.73578

ABSTRACT Passive daytime radiative cooling offers a carbon‑free route to mitigate urban heat islands and reduce building energy use. Conventional broadband emitters, however, suffer from parasitic absorption of ambient thermal radiation from hot ground and adjacent buildings, severely compromising net cooling in dense urban settings. We present a scalable, spectrally selective radiative cooling coating that overcomes this urban penalty. By combining a phase‑inversion‑derived micro‑nano porous poly (vinyl fluoride) (PVF) layer with a reflective silver substrate, our emitter achieves a record spectral selectivity of 1.37, with 97.5% solar reflectance and 94.4% mid‑infrared emittance strictly confined to the atmospheric window (8_13 µm). In simulated urban canyon tests, the selective emitter stayed 1.9°C cooler than a broadband counterpart, effectively neutralizing heat gain from surrounding infrastructure. The coating also exhibits excellent scalability, adhesion, self‑cleaning ability, and chemical durability. By bridging performance, manufacturability, and resilience, this work offers a viable pathway for adopting radiative cooling in sustainable urban development.

Clinical features and long-term outcome in children and adolescents with non-Hodgkin lymphoma: A report of the Taiwan Pediatric Oncology Group study TPOG-NHL-2010.

Journal of Clinical Oncology Yi-Lun Wang, Shih-Hsiang Chen, Chao-Ping Yang Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.258

258 Background: Children and adolescents with non-Hodgkin lymphoma (NHL) have different distributions of histologic subtypes and clinical characteristics compared to adult patients. In this study, we would like to report clinical features and treatment outcomes of children and adolescents with NHL by a national treatment protocol in Taiwan. Methods: We collected patients younger than 18 years of age diagnosed with NHL and registered to the Taiwan Pediatric Oncology Group (TPOG) between January 2008 and June 2023. All eligible patients were treated with the TPOG-NHL-2010 protocol, which was a BFM-based protocol without any targeted therapy and contained 5 regimens for major histology subtypes. The clinical features and treatment outcomes of patients with NHL were analyzed. Results: Four hundred and sixty-five children and adolescents with NHL were registered to the TPOG database. There were 303 boys and 162 girls. The median age at diagnosis was 11.8 years (range: 0.4 – 17.9 years). Advanced diseases accounted for 73.7% of patients at diagnosis (stage 3 in 215, stage 4 in 128). Burkitt/Burkitt-like lymphoma (23.7%) was the most prevalent histological subtypes, followed by diffuse large B cell lymphoma (23.0%), lymphoblastic lymphoma (22.8%), anaplastic large cell lymphoma (13.1%), and peripheral T cell lymphoma of (8.8%). Excluding 44 patients who had protocol violations or did not receive treatment with the TPOG protocol, 421 patients were eligible for further analysis. The median time of follow-up was 6.3 years. One patient had early loss to follow-up. Eleven patients had induction death, and 19 had induction failure. Among the remaining 390 patients who achieved remission, 47 had relapse, 4 developed 2 nd malignancy, and 2 had remission toxic death. Therefore, the 5-year overall survival and event-free survival were 86.5% and 80.5%, respectively. The 5-year event-free survival rates of for 4 major pediatric NHL subtypes were 87.6% for Burkitt/Burkitt-like lymphoma, 81.7% for diffuse large B cell lymphoma, 79.5% for lymphoblastic lymphoma, and 78.7% for anaplastic large cell lymphoma. Conclusions: The treatment outcome in children and adolescents with NHL in Taiwan was comparable with previous reports. Incorporation of more molecular analysis and potential targeted therapies could be considered for future trials.

Stereotactic body radiotherapy combined with chemotherapy and PD-1 inhibitor in oligometastatic nasopharyngeal carcinoma (STOMP): A prospective phase II clinical trial.

Journal of Clinical Oncology Jingjing Miao, Chong Zhao, Hai-Qiang Mai et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.232

232 Background: To evaluate the efficacy and safety of stereotactic body radiation therapy (SBRT) combined with gemcitibine plus cisplatin (GP) chemotherapy and PD-1 inhibitor in patients with oligometastatic nasopharyngeal carcinoma (NPC), registered on clincialtrials.gov (NCT05524168). Methods: Main eligibility criteria included diagnosed as oligometastasis NPC (≤5 lesions), and have ≥1 measurable lesion meeting the RECIST 1.1 criteria. Patients firstly receive SBRT for oligometastatic lesions (6-8Gy/fraction × 3-5 fractions), then receive GP+PD-1 inhibitor for 4-6 cycles followed by PD-1 inhibitor maintenance for 1 year. For patients with primary metastasis, the primary lesion and regional metastatic lymph nodes are given radiotherapy (RT) after completing 4-6 cycles of GP+PD-1 inhibitor. The primary endpoint was the 1-year progression-free survival (PFS) rate. Results: Between Nov 2022 to Jun 2025, 41 oligometastasis NPC patients were recruited (Table 1). 23 patients were primary metastases, and 17 had distant metastasis (DM) after receiving chemo-radiotherapy, and 1 had regional relapse and DM. All patients finished SBRT for metastatic lesions followed by GP+PD-1, and 23 patients with primary metastasis also received RT for primary lesions after 6 cycles of GP+PD-1. Then 17 received ≥1 year PD-1 maintenance, 3 discontinued for PD, 1 requested to withdraw, and 20 still under PD-1 maintenance. With the median follow-up time of 17.3 (IQR, 12.9-21.8) months, all these metastatic lesions receiving SBRT controlled well; 7 patients had disease progression, including 1 regional relapse, 4 DM, and 2 loco-regional relapse and DM, and all these lesions were newly developed metastatic lesions except one regional relapse which didn’t receive SBRT. The primary endpoint 1-year PFS rate was 92.2% (95%CI, 77.6-97.4%), and the secondary survival endpoints 1-year OS, DMFS and LRRFS rate were 100.0% (95%CI, 100-100%), 92.2% (95%CI, 77.6-97.4%), and 97.5% (95%CI, 83.5-99.6%), respectively. The best objective response rate (ORR) and disease control rate (DCR) before starting PD-1 maintenance were 92.7% and 100%, with 27 got complete response, 11 got partial response and 3 got stable disease. The median value of EBV DNA copies pretreatment was 743 (IQR, 151.5-5331.0) copies/ml, then decreased to 0 (IQR, 0-0) copies/ml post 6 cycles of GP+PD-1. No grade 5 therapeutic toxicity was observed in this trial. Conclusions: Patients with oligometastatic NPC who receive SBRT for metastatic lesions combined with GP and PD-1 inhibitor could achieve good therapeutic effects with acceptable toxicities. Clinical trial information: NCT05524168 . Basic information. Characteristic N (%) Median age (IQR), year 48 (39-54) Sex Female 13 (31.7) Male 28 (68.3) ECOG, points 0 4 (9.8) 1 37 (90.2) Number of metastases lesions 1-2 33 (80.5) 3-4 8 (19.5) Number of metastases organs 1 31 (75.6) 2 10 (24.4)

From intention to action in youth sustainable landscape engagement within urban residential communities

Scientific Reports Jun Du, Nor Atiah Ismail, Mohd Yazid Mohd Yunos et al. Jul 01, 2026 DOI: 10.1038/s41598-026-58656-y

Abstract Sustainable landscape practices in urban residential communities increasingly connect ecological governance, spatial renewal, and residents’ everyday lives in the context of globalization, urbanization, and post-pandemic urban change. However, youth participation at this micro-level remains limited. This study examines the low-participation of young residents aged 19–34 in sustainable community landscape practices in different types of urban residential communities in Zhengzhou, Henan, China. Drawing on a qualitative research design, this study conducted semi-structured interviews with 29 young residents who had engaged only minimally or had almost no involvement in such practices, and interpreted the data through reflexive thematic analysis. The findings suggest that young people’s low-participation does not simply stem from insufficient environmental awareness, but rather from the combined influence of multiple daily contextual factors. The study further shows that relational and responsibility-based motivations, together with experiential and belonging-based support, may activate participation intentions when community conditions are enabling. By situating youth engagement within everyday residential contexts, this study provides a micro-level explanation for the gap between sustainability awareness and action, and offers implications for youth-friendly sustainable community development.

Thermo‐Responsive Living Microspheroids Enable a Regenerative Living Disk–Drive System for DNA Data Storage

Advanced Materials Hao Luo, JinKai Gao, XiangXiang Huang et al. Jul 01, 2026 DOI: 10.1002/adma.73806

ABSTRACT DNA offers exceptional information density and long‐term stability, yet its practical deployment is limited by destructive readout and the absence of a reusable, physically addressable architecture that connects nanoscale molecular information with macroscale device‐level data organization. Here, we present a regenerative Living Disk–Drive system based on thermo‐responsive engineered living memory microspheroids (ELMMs), in which data‐encoded bacteria are encapsulated as discrete, file‐level living storage units. Each ELMM contains a clonal bacterial population carrying both an information plasmid, which encodes 26 × 26 pixel icon payloads and one‐ to three‐color intracellular fluorescent retrieval indices, and a help plasmid that enables CRISPR–Cas12a/λ‐Red rewriting of the data sequence and retrieval tag. A lyophilized ELMM database forms the Living Disk, which is coupled to an Optical Retriever and desktop‐scale Living Drive for closed‐loop retrieval, regeneration, and database replenishment. Released bacteria regrow for downstream readout or rewriting, while a fraction is re‐encapsulated into new ELMMs. The tested system retains retrieval, regrowth, and sequence recovery after four months of ambient dry storage and 13 lyophilization–rehydration cycles. Model‐based performance estimates are reported only as theoretical architecture‐level bounds. These results establish an experimentally bounded yet extensible architecture for physically manageable and regenerative DNA memory.

Advancing Stem Cell Bioprinting to Bridge Engineered and Natural Tissue Constructs

Advanced Materials Qi Gu Jul 01, 2026 DOI: 10.1002/adma.202510110

ABSTRACT The complexity of human organs arises from sophisticated cell interactions and dynamic, spatially precise developmental processes. Traditional tissue engineering and bioprinting technologies have made considerable progress, yet remain limited in reproducing the intricate structural and functional complexity of native organs. Stem cells, renowned for their differentiation capacity and responsiveness to environmental signals, offer a transformative opportunity to overcome these barriers. This review extensively covers recent progress in stem‐cell‐based organ manufacturing, highlights critical strategies to guide developmentally inspired organ fabrication, and explores the integration of intrinsic (cell‐intrinsic genetic networks and self‐organization) and extrinsic (bioink dynamics, microfabrication, and mechanical cues) approaches, forming the conceptual foundation for the convergence of instructive bioprinting and autonomous development. Collectively, these advances illustrate how integrating developmental biology principles with biofabrication precision is transforming tissue engineering from descriptive reconstruction toward predictive, functional organ manufacturing.

TP53–EGFR co-mutation landscape in Indian NSCLC: Decoding the genomic blueprint for targeted therapeutic decisions.

Journal of Clinical Oncology Vasanthkumar Muthukumar, Vijayalakshmi Ramshankar, Deepika Dash et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.267

267 Background: Lung cancer, especially non-small cell lung cancer (NSCLC), exhibits significant molecular heterogeneity that influences treatment response and clinical outcomes. This study aims to explore genetic variations and actionable alterations in Indian NSCLC patients to enhance precision medicine approaches. Methods: FFPE tumor tissue samples from 227 Indian lung cancer patients were analyzed using the 1Cell.Ai OncoTarget panel, a targeted NGS assay covering 126 genes associated with multi-cancer mutations, driver fusions, and microsatellite instability. Genomic DNA extraction, library preparation, and sequencing were performed on the Illumina NextSeq platform. Variant calling and clinical interpretation were conducted using the AI-driven iCARE software to identify somatic mutations, gene fusions, copy number variations (CNVs), and other genomic alterations. Therapeutic recommendations followed ACMG, AMP, ASCO, and CAP guidelines. Results: Comprehensive molecular profiling revealed frequent alterations in TP53 (116 cases; 51.1%), EGFR (98 cases; 43.2%), PIK3CA (20 cases; 8.8%), KRAS (15 cases; 6.6%), APC (12 cases; 5.3%), and ALK (11 cases; 4.8%). A clinically significant TP53–EGFR dual-mutation signature was observed in lung adenocarcinoma, with a high co-occurrence rate of approximately 59% (65 cases), defining a distinct molecular subtype characterized by differential responses to EGFR tyrosine kinase inhibitors, an increased propensity for accelerated therapeutic resistance, and a higher risk of aggressive disease progression. Additionally, KRAS co-mutation with TP53 was identified in 10 cases (66.67%), a pattern associated with adverse clinical outcomes, poorer prognosis, and reduced responsiveness to immunotherapy. Importantly, the detection of the KRAS G12C subtype highlights eligibility for targeted therapies such as sotorasib and adagrasib. Among evaluable cases for therapeutic recommendations (n = 160), EGFR mutations were present in 41.66% (67/160) and demonstrated favourable responses to EGFR-directed TKIs, although TP53 co-mutations contributed to resistance in a subset, while ALK fusions (15.63%; 25/160) showed marked sensitivity to ALK inhibitor–based targeted therapies. Conclusions: This study demonstrates the diverse genomic landscape of Indian NSCLC patients, highlighting TP53 and EGFR as key drivers. Notably, 160 of 227 patients (70.48%) received therapy recommendations based on genomic alterations, underscoring the translational value of targeted NGS panels in advancing precision medicine beyond conventional chemotherapy.

Molecular residual disease detection for ovarian cancer using a WGS-based ctDNA assay: Initial findings from the MONSTAR-SCREEN-3.

Journal of Clinical Oncology Fuminori Ito, Hiroshi Tanabe, Haruya Saji et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.202

202 Background: Ovarian cancer, including fallopian tube and primary peritoneal carcinoma, is often diagnosed at advanced stages. Although cytoreductive surgery and perioperative chemotherapy is a fundamental strategy, treatment outcomes remain unfavorable. Molecular residual disease (MRD) assessed by circulating tumor DNA (ctDNA) has emerged as a novel prognostic factor in multiple cancer types. However, ctDNA data in ovarian cancer remain limited, particularly using whole-genome sequencing (WGS)–based approaches. Methods: MONSTAR-SCREEN-3 is a prospective, multicenter study involving 1,100 patients (pts) with solid tumors, including ovarian cancer, undergoing curative treatment. Personalized panels (Precise MRD, Myriad Genetics) incorporating up to 1,000 targeted variants identified by WGS of matched tumor tissue were constructed. Plasma samples were collected sequentially at baseline, after preoperative chemotherapy, and at 1 month (M) post-surgery, every 3M during year 1, and every 6M during year 2. Results: As of December 2025, 65 pts with ovarian cancer were enrolled. Of whom, 40 ovarian cancer pts with both ctDNA results and clinical data available were included. 72.5% (29/40) were in FIGO stage III/IV, and 30 pts underwent upfront surgery and 10 pts received preoperative chemotherapy. Serous carcinoma was the most common histological type (50%). Thirty-five pts received curative-intent surgery, the majority of whom received adjuvant chemotherapy. Personalized panel creation was successful for all pts, with 82.5% achieving the maximum 1,000-variant panel. Among a total of 112 plasma samples passed quality control, 87 (77.7%) showed ctDNA positivity, with 26.4% (23/87) detected at an ultra-sensitive level (tumor fraction [TF] &lt; 100 parts per million [ppm]). ctDNA positivity at baseline (100% detected at TF over 100 ppm), 1M, and 3M post-surgery, were 100%, 76.7%, and 62.5%, respectively. Among post-operative samples, ultrasensitive-level detection was observed in 34.8% at 1M and 60% (9/15) at 3M, with a minimum TF of 2.4 ppm. Even in cases with macroscopic complete resection, only 27.8% (5/18) were MRD-negative. With a median follow-up of 3.7 months (0-13.3 months), three pts relapsed with a median lead time of 2.9 months (range, 0-6 months). Extended follow-up and longitudinal ctDNA data will be presented. Conclusions: In advanced ovarian cancer undergoing curative treatment, we reported the dynamics of ctDNA using a WGS-based ctDNA detection assay. Ovarian cancer demonstrated a high ctDNA-shedding phenotype; nevertheless, a clinically relevant subset of post-operative samples was detectable at ultrasensitive levels, underscoring the necessity of high-sensitivity assays. Further follow-up is warranted to establish the clinical significance of ultra-sensitive MRD detection in ovarian cancer. Clinical trial information: UMIN000053975 .

Direct Seawater Hydrogen Evolution via Atomically Precise Regulation of Interfacial pH and Ion‐Water Interactions

Angewandte Chemie International Edition Zhipu Zhang, Shanshan Lu, Qisheng Yan et al. Jul 01, 2026 DOI: 10.1002/anie.7140350

ABSTRACT Direct seawater electrolysis offers a sustainable route to green hydrogen production from abundant saline water resources, yet industrial applications are limited by sluggish kinetics and catalyst deactivation caused by Mg(OH) 2 /Ca(OH) 2 precipitation or Cl − corrosion. Here, we report a pH‐gradient‐mediated interfacial engineering strategy that simultaneously enhances activity and stability of metal nanocatalysts for the hydrogen evolution reaction (HER) in natural seawater. By using atomically precise Pt 6 (TPP) 4 Cl 5 nanoclusters (NCs) (Pt 6 ‐TPP, TPP = triphenylphosphine) as paradigm catalysts, we demonstrate self‐organized TPP ligands on cluster surface tether Na + /K + via cation–π interactions. The locally concentrated Na + /K + cations disrupt the hydrogen‐bond network of water molecules for accelerating HER kinetics, and electrostatically attract OH − to establish an alkaline interfacial pH, which can propagate into a diffuse pH gradient toward the bulk of the solution. This pH gradient drives Mg 2+ /Ca 2+ precipitation away from the catalytic surface, preventing site blockage. The enriched OH − can also resist Cl − corrosion of Pt 6 ‐TPP NCs. Consequently, Pt 6 ‐TPP achieves 10 mA cm −2 at an overpotential of 292 mV and retains exceptional stability (&gt; 500 h) under intermittent renewable‐energy operation, with one‐tenth the Pt loading of commercial Pt/C. This work establishes a pH gradient‐mediated interfacial chemistry framework enabled by atomically precise engineering, providing guidance for sustainable and efficient direct seawater hydrogen evolution.

Neural oscillations underlying the impact of the road environment on hazard perception

Scientific Reports Haihong Yu, Song Wang, Jianghai Hao et al. Jul 01, 2026 DOI: 10.1038/s41598-026-60611-w

A Nano‐Isolation Strategy for Tumor‐Activatable Photodynamic Therapy via Aggregation‐Gated Type I Photosensitizers

Advanced Materials Ping Liang, Longcai Liu, Yucheng Liu et al. Jul 01, 2026 DOI: 10.1002/adma.73771

ABSTRACT Photodynamic therapy (PDT) is hampered by high oxygen dependence and off‐target phototoxicity, and existing tumor‐activatable strategies are severely plagued by the aggregation‐induced reactive oxygen species (ROS) quenching post‐activation. We herein resolve these challenges through pioneering a smart “nano‐isolation” strategy, synergized with aggregatin‐induced emission (AIE)‐hemicyanine (Hcy) photosensitizers with an aggregation‐gated ROS generation feature. Propelled‐type AIE motifs were introduced to planar Hcy derivatives to construct twisted donor‐π‐acceptor photosensitizers, among which MTPAON with the largest conformational twist exhibited the best AIE effect and the highest ROS generation, predominantly generating less oxygen‐dependent type I ROS. Crucially, MTPAON's ROS generation is gated by aggregation degree, where only tightly packed aggregates activate ROS generation. Leveraging this, we pioneered a “nano‐isolation” strategy by encapsulating MTPAON in glutathione (GSH)‐responsive nanoparticles at a high polymer ratio (SSPEG‐7 NPs). This nano‐isolation initially suppresses MTPAON's tight aggregation and silences ROS generation. Upon encountering tumor‐overexpressed GSH, SSPEG‐7 NPs disassemble and release MTPAON to form type I ROS‐competent aggregates in tumor cells. SSPEG‐7 NPs thus demonstrated promising antitumor performance under low‐dose laser irradiation, while exhibiting negligible off‐target phototoxicity to normal tissues. This “nano‐isolation” strategy establishes a new paradigm for precision PDT: leveraging stimulus‐triggered aggregation to spatially control PDT activation, thereby reconciling the conflict between systemic safety and therapeutic potency.

Engineering Strain‐Stiffening Granular Hydrogels for 3D‐Printed Tissue‐Mimicry

Advanced Materials Hyeokju Chae, Joohwan Han, Jeong‐Wook Seo et al. Jul 01, 2026 DOI: 10.1002/adma.73527

ABSTRACT Biological tissues exhibit nonlinear strain‐stiffening behavior with distinct toe ( E Toe ) and heel ( E Heel ) moduli essential for load‐bearing function. However, synthetic materials lack a unified strategy and mechanistic basis for independently tuning E Toe and E Heel while maintaining high‐fidelity 3D printability. Here, we introduce a 3D‐printable strain‐stiffening double‐network granular hydrogel (SDGH) that enables region‐specific control of E Toe and E Heel through modulation of secondary‐network monomer concentration and microgel packing density, respectively. We elucidate the mechanism of strain‐stiffening behavior using in situ microscopic imaging and mechanical analysis. To demonstrate utility, we direct‐ink‐write multilayered aortic valves using alternating soft and stiff inks. The printed valves, selected for their demanding mechanical and heterogeneous architecture, showed high geometric fidelity and excellent hemodynamic performance, achieving regurgitation &lt;1.2% and surpassing ISO 5840 standards. This platform establishes a generalizable design framework for customized tissue mimetic organs for biomedical applications, particularly in synthetic surgical training material.